사전의사결정의 국제적 기준 및 원칙 제정방향 연구

연세대학교 / 의료법윤리학연구원

N1406_사전의사결정서 국제적 기준 및 원칙 제정 연구보고서.pdf

< 목 차 >
제1장 서론 ····························································································································· 1
제1절 연구의 배경 ············································································································· 1
제2절 연구의 목적 ············································································································· 3
제3절 연구의 방법 ············································································································· 4
제2장 사전의료지시서의 정의와 종류 ············································································· 5
제3장 사전의료지시서의 국외 현황 조사 ······································································· 7
제1절 미국 ··························································································································· 7
제2절 영국 ························································································································· 13
제3절 오스트리아 ············································································································· 14
제4절 프랑스 ····················································································································· 15
제5절 독일 ························································································································· 16
제6절 덴마크 ····················································································································· 17
제7절 일본 ························································································································· 18
제8절 싱가폴 ····················································································································· 22
제9절 대만 ························································································································· 23
제10절 국외 현황 조사 결과 ··························································································· 26
제4장 사전의료지시서의 국내 현황 조사 ····································································· 29
제1절 개관 ························································································································· 29
제2절 각 주체별 관점 ····································································································· 32
제3절 국내 사전의료지시서 ··························································································· 37
제5장 국내외 사전의료지시서 양식 조사 및 분석 ····················································· 39
제1절 미국 ························································································································· 39
제2절 독일 ························································································································· 54
제3절 대만 ························································································································· 57
제4절 한국 ························································································································· 60
제5절 소결 ························································································································· 69
- ii -
제6장 결론 및 제언 ··········································································································· 71
제1절 사전의료지시서 관련 필수적 고려사항 ··························································· 71
제2절 사전의료지시서의 장단점 ··················································································· 72
제3절 Guiding Principles on Advance Directives (draft) ···································4·· 7
제4절 WHO AD 국제적 기준 마련 위한 제안』계획안 ···································· 76
제5절 향후 연구를 위한 제언 ····················································································· 78
제7장 참 고 ························································································································· 80
제1절 관련 용어 정의 ····························································································· 80